SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Raymond James Maintains Outperform on ANI Pharmaceuticals, Lowers Price Target to $49

Raymond James maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Outperform and lowers the price target from $65 to $49.

Benzinga · 05/08/2020 12:29

Raymond James maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Outperform and lowers the price target from $65 to $49.